Resources
Measure What Matters
Cardiovascular disease remains the leading cause of death in the United States. A key risk factor is high cholesterol—specifically, high low-density lipoprotein (LDL), cholesterol.
A MINI Act Could Be Big for Heart Patients
The MINI Act would allow more time for research, investment and infrastructure in the development of novel therapies like genetically targeted technologies for heart patients.
Making Hypertension History for Veterans
Compared to the public, veterans suffer from higher rates of cardiovascular diseases and hypertension.
[Webinar] Will Patients Benefit from IRA’s Maximum Fair Price?
Listen to Robert Popovian, PharmD, Anne Sydor, PhD, and Ryan Gough as they discuss the impact of the Inflation Reduction Act's maximum fair price on patients.
Genetically Targeted Technologies: Targeted Treatment
Social media graphic
Genetically Targeted Technologies: Congress Can Help
Social media graphic
Genetically Targeted Technologies: Nobel Prize-Winning Science
Social media graphic
Veterans & Hypertension
Veterans suffer from higher rates of cardiovascular diseases, including hypertension.
